Skip to main content
Addgene

pSPORT-RREB1
(Plasmid #41145)

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 41145 Standard format: Plasmid sent in bacteria as agar stab 1 $85

Backbone

  • Vector backbone
    pSPORT6.1
  • Backbone size w/o insert (bp) 4149
  • Total vector size (bp) 9404
  • Vector type
    Mammalian Expression

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    XL10 Gold
  • Copy number
    Unknown

Gene/Insert

  • Gene/Insert name
    RREB-1
  • Alt name
    RREB1
  • Alt name
    hZIP
  • Species
    H. sapiens (human)
  • Insert Size (bp)
    5255
  • GenBank ID
    NP_001003698.1
  • Entrez Gene
    RREB1 (a.k.a. FINB, HNT, LZ321, RREB-1, Zep-1)
  • Promoter CMV
  • Tag / Fusion Protein
    • Flag (N terminal on insert)

Cloning Information

  • Cloning method Restriction Enzyme
  • 5′ cloning site AgeI (not destroyed)
  • 3′ cloning site XbaI (not destroyed)
  • 5′ sequencing primer SP6
  • 3′ sequencing primer T7
  • (Common Sequencing Primers)

Resource Information

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.

Depositor Comments

Please note: Plasmid contains the G195R natural variant in RREB1

How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pSPORT-RREB1 was a gift from Joshua Mendell (Addgene plasmid # 41145 ; http://n2t.net/addgene:41145 ; RRID:Addgene_41145)
  • For your References section:

    RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets. Kent OA, Fox-Talbot K, Halushka MK. Oncogene. 2012 Jul 2. doi: 10.1038/onc.2012.266. 10.1038/onc.2012.266 PubMed 22751122